↓ Skip to main content

Nutraceuticals in Acute and Prophylactic Treatment of Migraine

Overview of attention for article published in Current Treatment Options in Neurology, February 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
34 Mendeley
Title
Nutraceuticals in Acute and Prophylactic Treatment of Migraine
Published in
Current Treatment Options in Neurology, February 2016
DOI 10.1007/s11940-016-0398-1
Pubmed ID
Authors

Oved Daniel, Alexander Mauskop

Abstract

People who suffer from headaches often prefer nutraceutical treatment over traditional pharmacological approaches, due to fear of possible side effects, drug dependence, or addiction. Since treatment with nutraceuticals does not require a doctor's prescription, many patients rely on their own judgment as to when and which one to take, often without consultation or guidance from their physician. Some physicians could provide information about potential efficacy and side effects of various products, but many are not familiar with the nutraceuticals. Widespread skepticism persists among doctors about the effectiveness of these treatments. This is largely due to the lack of rigorous clinical studies. However, even when incontrovertible scientific evidence exists, many physicians remain distrustful of the evidence. The following review summarizes randomized controlled trials of some of the most commonly used non-pharmacological treatments, including magnesium, coenzyme Q10, riboflavin (vitamin B2), petasites, and feverfew (Table 1).

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Korea, Republic of 1 3%
Greece 1 3%
Unknown 31 91%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 24%
Unspecified 5 15%
Student > Doctoral Student 5 15%
Researcher 4 12%
Student > Bachelor 3 9%
Other 9 26%
Readers by discipline Count As %
Medicine and Dentistry 14 41%
Unspecified 6 18%
Agricultural and Biological Sciences 5 15%
Nursing and Health Professions 4 12%
Biochemistry, Genetics and Molecular Biology 2 6%
Other 3 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2016.
All research outputs
#9,590,657
of 12,486,432 outputs
Outputs from Current Treatment Options in Neurology
#236
of 330 outputs
Outputs of similar age
#173,515
of 270,803 outputs
Outputs of similar age from Current Treatment Options in Neurology
#9
of 11 outputs
Altmetric has tracked 12,486,432 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 330 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,803 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.